Largest single investment in the company's history in Germany
Rentschler Biopharma SE is planning to build a new buffer media station at the company's headquarters in Laupheim. According to the Rentschler press release, the aim of the new Attachment increase production efficiency. It is also intended to modernise the site so that it can continue to meet demand in the future. For the company, this is its largest Individual investment in Germany.
Services, order development
According to its own statement, Rentschler SE is a leading service and contract development organisation (CDMO) for biopharmaceuticals.
According to its press release, the family-owned company has been producing biopharmaceuticals for over 50 years. Buffer and media solutions are the essential basis of biopharmaceutical production.
Buffer media station on an area of 3,400 square metres
A four-storey building is now being erected. A modern buffer media station will be built there on an area of 3,400 square metres, according to the press release. The new building will be connected to the existing infrastructure.
The family business reports that detailed planning for this building has already begun. The construction phase is due to start in spring 2025. Rentschler has set the end of 2027 as the date for completion and commissioning, and the new buffer media station should be fully operational by 2028.